Study EV-103: New randomized cohort testing enfortumab vedotin as monotherapy or in combination with pembrolizumab in locally advanced or metastatic urothelial cancer Meeting Abstract
| Authors: | Mar, N.; Friedlander, T. W.; Hoimes, C. J.; Flaig, T. W.; Bilen, M. A.; Balar, A. V.; Henry, E.; Srinivas, S.; Rosenberg, J. E.; Petrylak, D. P.; Burgess, E. F.; Merchan, J. R.; Tagawa, S. T.; Carret, A. S.; Steinberg, J. L.; Chaney, M. F.; Milowsky, M. I. |
| Abstract Title: | Study EV-103: New randomized cohort testing enfortumab vedotin as monotherapy or in combination with pembrolizumab in locally advanced or metastatic urothelial cancer |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Language: | English |
| ACCESSION: | WOS:000560368309148 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.TPS5092 |
| Notes: | Meeting Abstract: TPS5092 -- Source: Wos |
